Erin E Vaughan

1.7k total citations
18 papers, 731 citations indexed

About

Erin E Vaughan is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Erin E Vaughan has authored 18 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Genetics. Recurrent topics in Erin E Vaughan's work include RNA Interference and Gene Delivery (7 papers), Mesenchymal stem cell research (6 papers) and Virus-based gene therapy research (4 papers). Erin E Vaughan is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Mesenchymal stem cell research (6 papers) and Virus-based gene therapy research (4 papers). Erin E Vaughan collaborates with scholars based in United States, Ireland and Germany. Erin E Vaughan's co-authors include David Allen Dean, David A. Dean, Timothy O’Brien, Mangesh Kulkarni, Aonghus O’Loughlin, Peter Dockery, Abhay Pandit, Frank Barry, Melissa Badding and Linda Howard and has published in prestigious journals such as PLoS ONE, Diabetes and Molecular Therapy.

In The Last Decade

Erin E Vaughan

17 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin E Vaughan United States 12 407 136 135 107 104 18 731
Takehiko Yamazaki Japan 12 307 0.8× 104 0.8× 211 1.6× 52 0.5× 67 0.6× 20 813
Bernard Martin United States 11 476 1.2× 87 0.6× 159 1.2× 135 1.3× 43 0.4× 12 1.1k
Michael K. Lichtman United States 6 267 0.7× 122 0.9× 62 0.5× 219 2.0× 70 0.7× 10 1.1k
Emmett Pinney United States 10 600 1.5× 53 0.4× 39 0.3× 97 0.9× 159 1.5× 12 1.1k
Dengqun Liu China 14 314 0.8× 60 0.4× 159 1.2× 57 0.5× 59 0.6× 35 822
Jonathan Coy United States 13 236 0.6× 77 0.6× 289 2.1× 69 0.6× 27 0.3× 17 716
Julie Devallière France 16 414 1.0× 115 0.8× 28 0.2× 84 0.8× 199 1.9× 22 972
Judith A. Mack United States 20 593 1.5× 113 0.8× 30 0.2× 170 1.6× 73 0.7× 35 1.2k
Yechen Xiao China 14 382 0.9× 46 0.3× 32 0.2× 114 1.1× 102 1.0× 29 731
Young-Doug Sohn South Korea 10 215 0.5× 58 0.4× 92 0.7× 31 0.3× 58 0.6× 11 409

Countries citing papers authored by Erin E Vaughan

Since Specialization
Citations

This map shows the geographic impact of Erin E Vaughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin E Vaughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin E Vaughan more than expected).

Fields of papers citing papers by Erin E Vaughan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin E Vaughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin E Vaughan. The network helps show where Erin E Vaughan may publish in the future.

Co-authorship network of co-authors of Erin E Vaughan

This figure shows the co-authorship network connecting the top 25 collaborators of Erin E Vaughan. A scholar is included among the top collaborators of Erin E Vaughan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin E Vaughan. Erin E Vaughan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kunnen, Steven J., Panuwat Trairatphisan, Ciarán Fisher, et al.. (2025). Spatio-temporal transcriptomic analysis reveals distinct nephrotoxicity, DNA damage, and regeneration response after cisplatin. Cell Biology and Toxicology. 41(1). 49–49. 1 indexed citations
2.
Dasgupta, Subham, Prathap Kumar S. Mahalingaiah, Brian N. Chorley, et al.. (2024). Urinary MicroRNA biomarkers of nephrotoxicity in Macaca fascicularis. Regulatory Toxicology and Pharmacology. 151. 105668–105668.
3.
Vaughan, Erin E, Elizabeth A. Connolly, Mun N. Hui, & Steven J. Chadban. (2020). Minimal change disease in a patient receiving checkpoint inhibition: Another possible manifestation of kidney autoimmunity?. Cancer Reports. 3(5). e1250–e1250. 8 indexed citations
4.
Liew, Aaron, Dilip Thomas, Erin E Vaughan, et al.. (2018). Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody. Cell Transplantation. 27(8). 1210–1221. 9 indexed citations
5.
Tongers, Jörn, Matthew J. Webber, Erin E Vaughan, et al.. (2014). Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix. Journal of Molecular and Cellular Cardiology. 74. 231–239. 23 indexed citations
6.
Coleman, Cynthia M., et al.. (2013). Growth Differentiation Factor-5 Enhances In Vitro Mesenchymal Stromal Cell Chondrogenesis and Hypertrophy. Stem Cells and Development. 22(13). 1968–1976. 73 indexed citations
7.
Kishore, Raj, Suresh K Verma, Alexander R Mackie, et al.. (2013). Bone Marrow Progenitor Cell Therapy-Mediated Paracrine Regulation of Cardiac miRNA-155 Modulates Fibrotic Response in Diabetic Hearts. PLoS ONE. 8(4). e60161–e60161. 67 indexed citations
8.
O’Loughlin, Aonghus, Mangesh Kulkarni, Erin E Vaughan, et al.. (2013). Topical Administration of Allogeneic Mesenchymal Stromal Cells Seeded in a Collagen Scaffold Augments Wound Healing and Increases Angiogenesis in the Diabetic Rabbit Ulcer. Diabetes. 62(7). 2588–2594. 112 indexed citations
9.
Mackie, Alexander R, Erin E Vaughan, S K Verma, et al.. (2013). Chronic ethanol consumption impacts post-AMI cardiac function and modulates gene expression in cardiac cell types through alteration of histone 3 lysine 79 methylation. Alcohol. 47(7). 572–572. 1 indexed citations
10.
O’Loughlin, Aonghus, Mangesh Kulkarni, Erin E Vaughan, et al.. (2013). Autologous circulating angiogenic cells treated with osteopontin and delivered via a collagen scaffold enhance wound healing in the alloxan-induced diabetic rabbit ear ulcer model. Stem Cell Research & Therapy. 4(6). 158–158. 27 indexed citations
11.
Vaughan, Erin E & Timothy O’Brien. (2012). Isolation of Circulating Angiogenic Cells. Methods in molecular biology. 916. 351–356. 19 indexed citations
12.
Badding, Melissa, Erin E Vaughan, & David A. Dean. (2011). Transcription factor plasmid binding modulates microtubule interactions and intracellular trafficking during gene transfer. Gene Therapy. 19(3). 338–346. 37 indexed citations
13.
Liew, Aaron, Jill McMahon, Thomas Ritter, et al.. (2009). Comparison of Viral and Nonviral Vectors for Gene Transfer to Human Endothelial Progenitor Cells. Tissue Engineering Part C Methods. 15(2). 223–231. 17 indexed citations
14.
Vaughan, Erin E, et al.. (2008). Microtubule Acetylation Through HDAC6 Inhibition Results in Increased Transfection Efficiency. Molecular Therapy. 16(11). 1841–1847. 61 indexed citations
15.
Vaughan, Erin E, et al.. (2006). Intracellular Trafficking of Plasmids for Gene Therapy: Mechanisms of Cytoplasmic Movement and Nuclear Import. Current Gene Therapy. 6(6). 671–681. 84 indexed citations
16.
Vaughan, Erin E & David Allen Dean. (2005). Intracellular Trafficking of Plasmids during Transfection Is Mediated by Microtubules. Molecular Therapy. 13(2). 422–428. 134 indexed citations
17.
Neumann, Paul, et al.. (2005). Peroxynitrite mediates TNF-α-induced endothelial barrier dysfunction and nitration of actin. American Journal of Physiology-Lung Cellular and Molecular Physiology. 290(4). L674–L684. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026